CRMD
CorMedix Inc. 9/4/2025, 10:35:19 AM
NasdaqGM
USD
EQUITY
At Close
$13.70
-0.52 (-3.62%)
Volume
4.36M
Market Cap
1.02B
NasdaqGM
Period
No AI Analysis Available
Generate a comprehensive AI analysis for CRMD to get insights on valuation, growth prospects, and investment recommendations.
Valuation
-
Profitability
38.3%
19.9%
23.0%
95.6%
40.6%
42.1%
Growth
14970.3%
894.9%
-
-
-
Financial Health
Forward Looking
Strong Buy
$16.83
-
$57.18
Small-Cap
Risk & Technical
1.77
$17.43 / $5.31
56.91
20.5%
Shareholder Returns
-
-
-
-13.9%
3.0%